Aflibercept, sold under the brand names Eylea and Zaltrap among others, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. [16][17] It was developed by Regeneron Pharmaceuticals.

May 21, 2024 · Aflibercept is an injectable eye preparation that is given by a healthcare provider every one to two months to treat the following retinal eye conditions: Diabetic retinopathy (DR) – an eye disorder in diabetics that can lead to a buildup of fluid in the retina and cause blindness.

Feb 1, 2025 · Aflibercept injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurred vision or blindness. Aflibercept works by changing the amount of blood that gets to the retina.

EYLEA® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Aflibercept, a humanized recombinant fusion protein, is a soluble decoy receptor that binds vascular endothelial growth factor-A (VEGF-A), VEGF-B, and placental growth factor (PIGF) [1] with a greater affinity than the body’s native receptors.

Jul 5, 2022 · Aflibercept is a medication used to treat and manage neovascular age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization, macular edema associated with retinal vein occlusion, and diabetic retinopathy.

Aug 5, 2024 · Aflibercept (Eylea, Pavblu) is commonly used for the following conditions. Learn more about Treating Diabetic Macular Edema with aflibercept. Aflibercept may also be used for other conditions...

EYLEA® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Aflibercept-ayyh injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina that causes blurred vision or blindness. Aflibercept-ayyh works by changing the amount of blood that gets to the retina.

Aflibercept injection products are used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities), diabetic macular edema (an eye disease caused by diabetes that can lead to vision loss),...